Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Cancer Medicine|June 22, 2021
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patientsAnand Patil, Bharati Shriyan, Parsshava Mehta, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 9, 2016
Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canalAmit Joshi, Nidhi Tandon, Vanita Noronha, et al.
The Bone & Joint Journal|July 8, 2020
The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fracturesBabar Kayani, Elliot Onochie, Vijay Patil, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2024
Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck CancerVanita Noronha, Vijay Patil, Nandini Menon, et al.
Journal of Neuro-Oncology|June 26, 2019
Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgroupingTejpal Gupta, Madan Maitre, Goda Jayant Sastri, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|December 5, 2017
Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer CenterAnant Ramaswamy, Amit Joshi, Vanita Noronha, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in DiagnosticsAnuradha Chougule, Vinita Jagtap, Ankita Nikam, et al.
Ecancermedicalscience|July 18, 2024
Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world dataVanita Noronha, Harsh Sahu, Akhil Kapoor, et al.
Journal of Clinical and Diagnostic Research : JCDR|April 8, 2017
TRUS Biopsy Yield in Indian Population: A Retrospective AnalysisSunil Raghunath Patil, Prakash Wamanrao Pawar, Ajit Somaji Sawant, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Cancer Medicine|June 22, 2021
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patientsAnand Patil, Bharati Shriyan, Parsshava Mehta, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 9, 2016
Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canalAmit Joshi, Nidhi Tandon, Vanita Noronha, et al.
The Bone & Joint Journal|July 8, 2020
The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fracturesBabar Kayani, Elliot Onochie, Vijay Patil, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2024
Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck CancerVanita Noronha, Vijay Patil, Nandini Menon, et al.
Journal of Neuro-Oncology|June 26, 2019
Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgroupingTejpal Gupta, Madan Maitre, Goda Jayant Sastri, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|December 5, 2017
Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer CenterAnant Ramaswamy, Amit Joshi, Vanita Noronha, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in DiagnosticsAnuradha Chougule, Vinita Jagtap, Ankita Nikam, et al.
Ecancermedicalscience|July 18, 2024
Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world dataVanita Noronha, Harsh Sahu, Akhil Kapoor, et al.
Journal of Clinical and Diagnostic Research : JCDR|April 8, 2017
TRUS Biopsy Yield in Indian Population: A Retrospective AnalysisSunil Raghunath Patil, Prakash Wamanrao Pawar, Ajit Somaji Sawant, et al.
Pageof 19